RS65243B1 - Jedinjenje [1,2,4]triazolo[1,5-a]piridina kao inhibitor jak i njegova primena - Google Patents
Jedinjenje [1,2,4]triazolo[1,5-a]piridina kao inhibitor jak i njegova primenaInfo
- Publication number
- RS65243B1 RS65243B1 RS20240239A RSP20240239A RS65243B1 RS 65243 B1 RS65243 B1 RS 65243B1 RS 20240239 A RS20240239 A RS 20240239A RS P20240239 A RSP20240239 A RS P20240239A RS 65243 B1 RS65243 B1 RS 65243B1
- Authority
- RS
- Serbia
- Prior art keywords
- triazolo
- application
- pyridine compound
- jak inhibitor
- jak
- Prior art date
Links
- 229940122245 Janus kinase inhibitor Drugs 0.000 title 1
- -1 [1,2,4]triazolo[1,5-a]pyridine compound Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810968207 | 2018-08-23 | ||
| PCT/CN2019/102209 WO2020038457A1 (zh) | 2018-08-23 | 2019-08-23 | 作为JAK抑制剂的[1，2，4]三唑并[1，5-a]吡啶类化合物及其应用 |
| EP19852944.8A EP3842431B1 (en) | 2018-08-23 | 2019-08-23 | [1,2,4]triazolo[1,5-a]pyridine compound as jak inhibitor and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS65243B1 true RS65243B1 (sr) | 2024-03-29 |
Family
ID=69592871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20240239A RS65243B1 (sr) | 2018-08-23 | 2019-08-23 | Jedinjenje [1,2,4]triazolo[1,5-a]piridina kao inhibitor jak i njegova primena |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11919896B2 (sr) |
| EP (1) | EP3842431B1 (sr) |
| JP (1) | JP7140920B2 (sr) |
| KR (1) | KR102603729B1 (sr) |
| CN (1) | CN112739696B (sr) |
| AU (1) | AU2019326647B2 (sr) |
| CA (1) | CA3106490C (sr) |
| RS (1) | RS65243B1 (sr) |
| WO (1) | WO2020038457A1 (sr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220127900A (ko) * | 2020-02-13 | 2022-09-20 | 주하이 유나이티드 라보라토리즈 컴퍼니 리미티드 | Jak 키나아제 관련 질병의 치료를 위한 약물의 제조에 있어서 jak 억제제의 용도 |
| US20230091250A1 (en) * | 2020-02-21 | 2023-03-23 | Zhuhai United Laboratories Co., Ltd. | Crystalline form of jak inhibitor and application thereof |
| US20240033255A1 (en) | 2021-01-29 | 2024-02-01 | Zhuhai United Laboratories Co., Ltd. | Oral preparation containing jak inhibitor or salt thereof or crystal form thereof, preparation method therefor, and application thereof |
| AU2022330231A1 (en) | 2021-08-19 | 2024-04-04 | Zhuhai United Laboratories Co., Ltd. | Local topical formulation containing jak inhibitor or salt thereof or crystal form thereof, preparation method therefor and application thereof |
| WO2023076161A1 (en) | 2021-10-25 | 2023-05-04 | Kymera Therapeutics, Inc. | Tyk2 degraders and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090220688A1 (en) | 2005-07-27 | 2009-09-03 | Buddy Tools, Llc | Drywall tape and joint compound dispenser |
| WO2010010187A1 (en) * | 2008-07-25 | 2010-01-28 | Galapagos Nv | Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| JO3041B1 (ar) * | 2008-07-25 | 2016-09-05 | Galapagos Nv | مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية |
| AR077468A1 (es) * | 2009-07-09 | 2011-08-31 | Array Biopharma Inc | Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa |
| WO2018019222A1 (zh) * | 2016-07-26 | 2018-02-01 | 张文燕 | 作为jak抑制剂杂环化合物，该化合物的盐类及其治疗用途 |
| CA2939286A1 (en) * | 2016-08-17 | 2018-02-17 | Pharmascience Inc. | Spirocyclic containing compounds and pharmaceutical uses thereof |
| CN108341814B (zh) * | 2017-01-23 | 2021-09-03 | 上海翔锦生物科技有限公司 | Jak激酶抑制剂及其应用 |
| CA3072346A1 (en) * | 2017-08-14 | 2019-02-21 | Camp4 Therapeutics Corporation | Methods of treating liver diseases |
-
2019
- 2019-08-23 AU AU2019326647A patent/AU2019326647B2/en active Active
- 2019-08-23 EP EP19852944.8A patent/EP3842431B1/en active Active
- 2019-08-23 KR KR1020217008505A patent/KR102603729B1/ko active IP Right Grant
- 2019-08-23 CN CN201980041955.2A patent/CN112739696B/zh active Active
- 2019-08-23 US US17/263,416 patent/US11919896B2/en active Active
- 2019-08-23 JP JP2021534418A patent/JP7140920B2/ja active Active
- 2019-08-23 RS RS20240239A patent/RS65243B1/sr unknown
- 2019-08-23 WO PCT/CN2019/102209 patent/WO2020038457A1/zh active Application Filing
- 2019-08-23 CA CA3106490A patent/CA3106490C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3842431A4 (en) | 2022-06-01 |
| EP3842431C0 (en) | 2023-12-27 |
| US11919896B2 (en) | 2024-03-05 |
| CN112739696A (zh) | 2021-04-30 |
| AU2019326647A1 (en) | 2021-02-18 |
| EP3842431B1 (en) | 2023-12-27 |
| US20210155621A1 (en) | 2021-05-27 |
| JP7140920B2 (ja) | 2022-09-21 |
| CA3106490C (en) | 2023-03-07 |
| CN112739696B (zh) | 2022-08-02 |
| AU2019326647B2 (en) | 2022-02-10 |
| JP2021534259A (ja) | 2021-12-09 |
| CA3106490A1 (en) | 2020-02-27 |
| EP3842431A1 (en) | 2021-06-30 |
| KR102603729B1 (ko) | 2023-11-17 |
| KR20210049858A (ko) | 2021-05-06 |
| WO2020038457A1 (zh) | 2020-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS65243B1 (sr) | Jedinjenje [1,2,4]triazolo[1,5-a]piridina kao inhibitor jak i njegova primena | |
| HK1258157A1 (zh) | 作為jak抑制劑的吡唑並[1，5-a]吡嗪-4-基衍生物 | |
| EP3107914B8 (en) | Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as cdk inhibitors and their therapeutic use | |
| IL281127A (en) | Pyrazolo[3,4-B]pyridine compounds as inhibitors of TAM and MET kinases | |
| EP3280715A4 (en) | NOVEL 5 OR 8 SUBSTITUTED IMIDAZO [1,5-A] PYRIDINS AS INDOLEAMINE AND / OR TRYPTOPHANE 2,3-DIOXYGENASES | |
| EP3345907A4 (en) | NOVEL COMPOUND PYRROLO [3,4-d] PYRIMIDINE OR CORRESPONDING SALT | |
| EP3849983A4 (en) | TRIAZOLEPYRIMIDINE COMPOUNDS AND USES THEREOF | |
| EP3268000A4 (en) | Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors | |
| ZA201902562B (en) | Pyrazolo [1,5-a]pyridine derivatives and their use as pesticides | |
| EP3543242A4 (en) | 8,9-DIHYDROIMIDAZOLE [1,2-A] PYRIMIDO [5,4-E] PYRIMIDINE-5 (6H) KETONE COMPOUND | |
| EP3424928A4 (en) | HETEROCYCLIC NITROGEN COMPOUND, PREPARATION METHOD, INTERMEDIATE, COMPOSITION AND USE | |
| EP3710431A4 (en) | SUBSTITUTED PYRROLOPYRIMIDINE JAK INHIBITORS AND METHODS FOR THEIR MANUFACTURE AND USE | |
| IL262673A (en) | Pyrazolo[1,5-a]pyrimidine compound | |
| EP3981769A4 (en) | PYRROLOPYRIMIDINE COMPOUND AND USE | |
| EP4074710A4 (en) | PYRAZOLO[1,5-A]PYRIDINE COMPOUND, PREPARATION METHOD AND USE THEREOF | |
| IL290419A (en) | Imidazo[a-1,5]pyrazine derivatives as inhibitors of pi3k delta | |
| EP3666774A4 (en) | 1H-PYRAZOLO [4.3-H] QUINAZOLINE COMPOUND FOR USE AS A KINASE PROTEIN INHIBITOR | |
| IL272988A (en) | Imidazo-[1,5-A]pyrazine derivatives as PI3K-delta inhibitors | |
| EP3730492A4 (en) | COMPOUND PYRAZOLO [1,5-A] PYRIMIDINE SUBSTITUTE, PHARMACEUTICAL COMPOSITION AND ASSOCIATED USE | |
| EP3689871A4 (en) | 1,2-DIHYDROPYRROL [3,4-C] PYRIDIN / PYRIMIDIN-3-ONE DERIVATIVE 4,6,7-TRISUBSTITUDE AND ITS USE | |
| EP3719023A4 (en) | 6,7-DIHYDROPYRAZOLO [1,5-a] DERIVATIVE PYRAZINONE AND ITS MEDICAL APPLICATION | |
| EP3600292A4 (en) | PROCESS FOR THE MANUFACTURING OF TRIAZOLE [4,5D] PYRAMIDINE DERIVATIVES AND INTERMEDIATES THEREOF | |
| EP3727379A4 (en) | PYRAZOLO [1,5-A] PYRIDINE DERIVATIVE SALTS AND THEIR USE | |
| EP3985007A4 (en) | TRIAZOLOPYRIMIDINE COMPOUND AND SALT, COMPOSITION AND USE THEREOF | |
| EP4028400A4 (en) | SUBSTITUTED IMIDAZOQUINOXALINE COMPOUNDS AND THEIR USES |